标题
Identification of VKORC1 genotype leading to resistance to tecarfarin
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 54, Issue 8, Pages 896-900
出版商
Wiley
发表日期
2014-05-17
DOI
10.1002/jcph.332
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces
- (2013) K. J. Czogalla et al. BLOOD
- VKORC1L1, an Enzyme Rescuing the Vitamin K 2,3-Epoxide Reductase Activity in Some Extrahepatic Tissues during Anticoagulation Therapy
- (2013) Abdessalem Hammed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells
- (2013) J.-K. Tie et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- VKORC1mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity
- (2012) A. HODROGE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants
- (2011) Ahmed Hodroge et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants
- (2010) Linda M. Bavisotto et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment
- (2010) M. WATZKA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A newVKORC1mutation leading to an isolated resistance to fluindione
- (2009) Katell Peoc’h et al. BRITISH JOURNAL OF HAEMATOLOGY
- VKORC1mutations in patients with partial resistance to phenprocoumon
- (2009) Peter C. J. Schmeits et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of tecarfarin, a novel vitamin K epoxide reductase inhibitor, on coagulation in beagle dogs
- (2009) A Choppin et al. BRITISH JOURNAL OF PHARMACOLOGY
- The First Evaluation of a Novel Vitamin K Antagonist, Tecarfarin (ATI-5923), in Patients With Atrial Fibrillation
- (2009) David J. Ellis et al. CIRCULATION
- Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats
- (2009) Agnes Grandemange et al. Pharmacogenetics and Genomics
- Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
- (2008) Jonatan D. Lindh et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions inVKORC1
- (2008) D. J. HARRINGTON et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans
- (2008) L. BODIN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More